Schizophrenia: gender, family risk, and plasma homovanillic acid. 1995

R Dávila, and M Zumárraga, and M A González-Torres, and I Andía, and M I Zamalloa, and E Basterreche, and J Guimón, and A J Friedhoff
Departmento de Investigación Neuroquímica, Servicio Vasco de Salud, Vizcaya, Spain.

Plasma homovanillic acid concentration was assessed in 60 young schizophrenic patients, with and without first-degree relatives with schizophrenia, before treatment, and 3 days after starting haloperidol treatment. The baseline concentration of homovanillic acid in plasma was no different in the two groups before treatment; it was, however, significantly higher in the patients with relatives than in those without relatives diagnosed of schizophrenia after 3 days of haloperidol treatment.

UI MeSH Term Description Entries
D008297 Male Males
D005190 Family A social group consisting of parents or parent substitutes and children. Family Life Cycles,Family Members,Family Life Cycle,Family Research,Filiation,Kinship Networks,Relatives,Families,Family Member,Kinship Network,Life Cycle, Family,Life Cycles, Family,Network, Kinship,Networks, Kinship,Research, Family
D005260 Female Females
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006719 Homovanillic Acid A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid. 3-Methoxy-4-Hydroxyphenylacetic Acid,4-Hydroxy-3-Methoxyphenylacetic Acid,3 Methoxy 4 Hydroxyphenylacetic Acid,4 Hydroxy 3 Methoxyphenylacetic Acid,Acid, 3-Methoxy-4-Hydroxyphenylacetic,Acid, 4-Hydroxy-3-Methoxyphenylacetic,Acid, Homovanillic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder

Related Publications

R Dávila, and M Zumárraga, and M A González-Torres, and I Andía, and M I Zamalloa, and E Basterreche, and J Guimón, and A J Friedhoff
January 1991, Biological psychiatry,
R Dávila, and M Zumárraga, and M A González-Torres, and I Andía, and M I Zamalloa, and E Basterreche, and J Guimón, and A J Friedhoff
January 2001, Acta pharmacologica Sinica,
R Dávila, and M Zumárraga, and M A González-Torres, and I Andía, and M I Zamalloa, and E Basterreche, and J Guimón, and A J Friedhoff
March 1988, Psychiatry research,
R Dávila, and M Zumárraga, and M A González-Torres, and I Andía, and M I Zamalloa, and E Basterreche, and J Guimón, and A J Friedhoff
March 2000, Biological psychiatry,
R Dávila, and M Zumárraga, and M A González-Torres, and I Andía, and M I Zamalloa, and E Basterreche, and J Guimón, and A J Friedhoff
August 1995, Biological psychiatry,
R Dávila, and M Zumárraga, and M A González-Torres, and I Andía, and M I Zamalloa, and E Basterreche, and J Guimón, and A J Friedhoff
January 2001, Journal of psychiatric research,
R Dávila, and M Zumárraga, and M A González-Torres, and I Andía, and M I Zamalloa, and E Basterreche, and J Guimón, and A J Friedhoff
December 1992, Archives of general psychiatry,
R Dávila, and M Zumárraga, and M A González-Torres, and I Andía, and M I Zamalloa, and E Basterreche, and J Guimón, and A J Friedhoff
September 2000, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
R Dávila, and M Zumárraga, and M A González-Torres, and I Andía, and M I Zamalloa, and E Basterreche, and J Guimón, and A J Friedhoff
February 1994, Archives of general psychiatry,
R Dávila, and M Zumárraga, and M A González-Torres, and I Andía, and M I Zamalloa, and E Basterreche, and J Guimón, and A J Friedhoff
January 2006, Schizophrenia research,
Copied contents to your clipboard!